Oxidative DNA lesions inhibit the transcription of RNA polymerase II, but in the presence of transcription elongation factors, the transcription can bypass the lesions. Single-subunit mitochondrial RNA polymerase (mtRNAP) catalyses the synthesis of essential transcripts in mitochondria where reactive oxidative species (ROS) are generated as by-products. The occurrence of RNA synthesis by mtRNAP at oxidative DNA lesions remains unknown. Purified mtRNAP and a complex of RNA primer/DNA template containing a single DNA lesion, such as ROS-induced 8-oxoguanine (8-oxoG), two isomeric thymine glycols (5R-Tg or 5S-Tg), the UV-induced cis-syn cyclobutane pyrimidine dimer (CPD) and the pyrimidine(6-4)pyrimidone photoproduct (6-4pp), or a spontaneous common DNA lesion, a base-loss-induced apurinic/apyrimidinic (AP) site, were used for in vitro RNA synthesis assays. In this report, we show that mtRNAP bypassed the oxidative DNA lesions of non-bulky 8-oxoG and 5R-Tg and 5S-Tg with pausing sites but did not bypass the UV-induced DNA lesions and the AP site. The bacteriophage T7 phage RNA polymerase, which is homologous to mtRNAP, bypassed 8-oxoG but stalled at 5R-Tg and 5S-Tg. As expected, although translesion RNA synthesis in 8-oxoG on the DNA templates generated incorrect transcripts with a G:C to T:A transversion, the synthesis in Tg could lead to the correct transcripts with no transcriptional mutagenesis. Collectively, these data suggest that mtRNAP may tolerate the mitochondrial genome containing oxidative DNA lesions induced by ROS from the side effects of an ATP generation reaction.
Introduction
Cellular DNA carrying genetic information is prone to deterioration and modifications due to environmental influences and endogenous damage. DNA damage interferes with essential DNA-dependent processes, such as replication and transcription, and triggers mutations or cell death. To date, the majority of DNA repair and mutagenesis studies are based on the actions of DNA polymerases during the replication process. However, the presence of DNA lesions interferes not only with replication but also with transcription. Notably, non-dividing cells, such as heart muscle cells and nerve cells, are terminally differentiated post-mitotic cells that are extremely active in transcription but not replication (1) (2) (3) . Therefore, understanding the effect of transcription on the transcribed strand containing DNA lesions might help to explain the risk of DNA lesions in living cells (4, 5) .
Transcription-coupled repair (TCR) can remove a wide variety of DNA lesions from transcribed strands of DNA. This repair system is highly conserved from bacteria to humans. In the molecular mechanism of TCR, it is thought that the blockage of the transcriptional machinery at the damaged DNA site of the transcribed strand triggers TCR and recruits other DNA repair factors to remove the transcription-blocking lesions on the transcribed strand (6) (7) (8) . Conversely, when DNA lesions on the transcribed strands are not repaired by TCR or by other repair pathways, RNA polymerase might generate mutations in the RNA (transcriptional mutagenesis) (9) (10) (11) . In this case, the mutated transcripts coding aberrant proteins are thought to have a dominant-negative effect for cells (12, 13) .
Mitochondria provide the majority of energy in eukaryotic cells by generating most of the adenosine triphosphate (ATP). The production of ATP is driven by the energy of oxidation (oxidative phosphorylation) using the respiratory enzyme complexes, and the generation of ROS as by-products of ATP synthesis is induced at the same time. Each mitochondrion carries its own multicopy genome DNA coding for 13 essential polypeptides, 22 transfer RNAs and 2 ribosomal RNAs, all of which are essential for electron transport and ATP generation. The mitochondrial DNA (mtDNA) exists inside the organelle in the presence of high oxidative stress from by-products, and there is no protection provided by histone proteins, which ordinarily wrap nuclear DNA (nDNA). Therefore, mtDNA contains higher levels of oxidative DNA lesions [e.g. 8-oxoguanine (8-oxoG), 2-hydroxyadenine and Tg] and exhibits a higher mutation rate compared with nDNA. Various human diseases including cancer are associated with mutations in mitochondrial genes (14) (15) (16) .
The transcription of the mtDNA is a unique process, which is similar to bacteria, although the transcription factors including an mitochondrial RNA polymerase (mtRNAP) are encoded in nDNA. Unlike the 12-subunit RNA polymerase II in mammalian cells, mtRNAP consists of a single subunit and is homologous to those polymerases encoded by bacteriophages T3 and T7 (17, 18) . Only mtRNAP can perform the transcription of the entire mitochondrial genome coding for the essential subunits of the respiratory enzyme complexes. Additionally, the mtRNAP encounters many DNA lesions induced by the ROS generated in the mitochondria.
Herein, using purified mtRNAP and an RNA primer/DNA lesion containing template, we investigated whether the purified mtRNAP bypasses at the DNA lesions [ROS-induced DNA lesions: 8-oxoG and Tg, UV-induced DNA lesions: cyclobutane pyrimidine dimer (CPD) and pyrimidine(6-4)pyrimidone photoproduct (6-4pp) and base-loss-induced DNA lesions: apurinic/apyrimidinic (AP) site] on the transcribed strand during the in vitro transcription, and we also investigated whether mtRNAP induces transcriptional mutagenesis near these DNA lesions.
Materials and methods

Materials
The 30-mer DNA templates containing CPD (19), 6-4pp (20) , 5R-Tg (21) and 5S-Tg (22) were synthesised on an Applied Biosystems 3400 DNA synthesiser, as previously described, and those templates containing 8-oxoG and the AP site analogue (dSpacer) were synthesised using phosphoramidite building blocks purchased from Glen Research.
The RNA primers were synthesised and purified using high-performance liquid chromatography (FASMAC). The RNA sequence used for the running start transcription was 5ʹ-ACUGUAUGA-3ʹ and that used for the standing start transcription was 5ʹ-UGUAUGAUG-3ʹ. The oligonucleotides were 5ʹ-phosphorylated using [γ-
32 P] ATP (PerkinElmer Life Sciences) and T4 phosphoramidite kinase (TaKaRa). The unincorporated nucleotides were removed using MicroSpin G-25 Columns (GE Healthcare).
The recombinant human mtRNAP was purified as described previously (23) . T7 RNA polymerase and RNase inhibitor were obtained from TOYOBO. RNase-free, non-DEPC water was obtained from BioDynamics Laboratory, and heparin was obtained from Wako.
In vitro RNA synthesis assays
The 5ʹ-32 P-labelled RNA primer/DNA template complex was prepared by mixing an RNA primer with one of the DNA templates containing an indicated DNA lesion at a molar ratio of 1:1. The 10-µl reaction mixtures containing 10 mM Tris-HCl (pH 8.0), 10 mM MgCl 2 , 1 mM dithiothreitol, 100 µg/ml bovine serum albumin, 20 units RNase inhibitor (TOYOBO), 100 µM UTP, 40 nM of a labelled RNA primer/DNA template complex and mtRNAP were incubated at room temperature (RT) for 20 min. Then, 1 µl of heparin (2 mg/ml) was added, and the solution was incubated at RT for 10 min to prevent further RNA synthesis (24) (25) (26) (27) . In the presence of heparin, RNA synthesis increased linearly up to 36 fmol of mtRNAP in the mtRNAP concentration-dependent manner. But in the absence of heparin, the enzyme was not able to linearly generate RNA transcripts in the concentration-dependent manner (supplementary Figure S1 , available at Mutagenesis Online). Therefore, this condition is thought to be a single round transcription. Next, 100 µM ATP, CTP and GTP was added to allow for the initiation of RNA synthesis, and the sample was incubated at 32°C for 20 min for a running start transcription or for 5 min for a standing start transcription. The reactions were terminated by the addition of 10 µl of a stop solution containing 95% formamide, 10 mM EDTA, 0.025% bromophenol and 0.025% xylene cyanol. The transcription products were separated by electrophoresis on a denaturing 16 or 20% polyacrylamide gel, dried and analysed using a FUJIFILM BAS 1800 bio-image analyzer (28) (29) (30) .
Results
Endogenous ROS are largely formed during oxidative phosphorylation in the mitochondria; therefore, mtDNA is at a particularly high risk of ROS-induced damage (16, 31) . One of the most common oxidative DNA lesions is 8-oxoG, which is repaired primarily by the base excision repair (BER) pathway. To investigate the effects of the DNA lesion on the transcription reaction catalysed by mtRNAP in the mitochondria, 30-mer oligonucleotide templates containing an 8-oxoG lesion or an AP site were hybridised to a 5ʹ-32 P-labelled 9-mer oligonucleotide RNA primer (RNA9-R), and these duplexes ( Figure 1A) were employed for the running start transcription. Heparin was added to prevent further RNA synthesis (24) (25) (26) (27) . During transcription by RNAPs under these conditions, the non-transcribed strand is not required for transcription (30) , and the stability of RNAP elongation complexes is unaffected by the absence of the strand (28) . The mtRNAP could synthesis RNA products of up to 25 nucleotides in length on the control template ( Figure 1B , lanes 2-4). Under these conditions, RNA synthesis increased linearly up to 36 fmol of mtRNAP, suggesting that the non-template DNA strand is not required for this transcription reaction by mtRNAP, as shown previously in other RNA polymerases. When the template DNA containing an 8-oxoG lesion was used, mtRNAP could catalyse some translesion RNA synthesis at any enzyme concentration ( Figure 1B, lanes 6-8) , suggesting that the transcription reaction in mitochondria is not completely blocked by the 8-oxoGs on the transcribed DNA strand. The amount of bypassed transcripts (>13 nt) that was produced by 36 fmol of mtRNAP on the 8-oxoG template was 46% ( Figure 1B, lane 8) , while the amount of transcripts (>13 nt) on the control G template was 78% ( Figure 1B, lane 4) . This enzyme also generated some RNA products that were shown to be 11 nucleotides in length. The RNA products indicate that mtRNAP was unable to bypass an 8-oxoG lesion by the non-incorporation of rNTPs opposite the lesions. Using DNA templates with an AP site, mtRNAP generated 11 nucleotides, indicating that mtRNAP could not incorporate any ribonucleotides opposite the AP site ( Figure 1B, lanes 10-12) . The data suggest that AP sites that are non-coding DNA lesions significantly block the transcription reaction in mitochondria.
An 8-oxoG is a premutagenic lesion due to its potential to mispair with adenine by replicative DNA polymerases during DNA replication (2) . To examine the ribonucleotide preference for incorporation opposite an 8-oxoG site by mtRNAP, standing start transcriptions were performed in the presence of only a single ribonucleotide (Figure 2A) . When guanine was used as a control on the DNA template, cytidine triphosphate (rCTP) was incorporated ( Figure 2B, lane 2) . On a DNA template containing an 8-oxoG site, mtRNAP preferred to incorporate the 'incorrect' rAMP to an extent of up to 11 ribonuleotides instead of incorporating the 'correct' rCMP opposite the DNA lesion ( Figure 2B , lanes 5 and 6).
In contrast, using a template containing an AP site, mtRNAP could not incorporate any rNTPs opposite an AP site, indicating that the enzyme almost completely stalls at this site ( Figure 2B , lanes 9-12).
Tg is one candidate of the major DNA lesions induced in mtDNA by ROS, and two isomeric forms, 5R-Tg and 5S-Tg, are produced. Tg often blocks the DNA replication catalysed by replicative DNA polymerases (32) . Additionally, purified human RNA polymerase II was unable to bypass the lesion (25, 33) . Using the 30-mer oligonucleotides containing a single Tg with a 5ʹ-32 P-labelled 9-mer RNA primer ( Figure 3A) , we examined whether mtRNAP can generate transcripts on 5R-Tg and 5S-Tg. Interestingly, mtRNAP could catalyse some translesion RNA synthesis past both isomeric forms at any enzyme concentration ( Figure 3B, lanes 5-12) . The amount of transcripts (>13 nt) that was produced by 36 fmol of mtRNAP on control T ( Figure 3B , lane 4), on 5R-Tg ( Figure 3B, lane 8) or on 5S-Tg ( Figure 3B , lane 12) was 79, 29 or 40%, respectively. Compared with the control DNA templates that did not contain lesions ( Figure 3B,  lanes 1-4) , mtRNAP generated some RNA products that were shown to be mainly 11 or 12 nucleotides in length.
Tg does not significantly induce mutations during DNA replication because it blocks DNA polymerase. To examine the ribonucleotide preference for incorporation opposite a 5R-Tg or a 5S-Tg site by mtRNAP, standing start transcriptions were performed ( Figure 4A ). When thymine was used as a control on the DNA template, adenine triphosphate (rATP) was incorporated ( Figure 4B, lane 1) . On a DNA template containing a 5R-Tg site, mtRNAP preferred to incorporate the 'correct' rAMP opposite the lesion to an extent of up to 11 ribonuleotides ( Figure 4B, lane 5) . Additionally, using a template containing a 5S-Tg site, similar results were obtained ( Figure 4B, lane 9) . The data suggested that mtRNAP bypasses the two isomeric Tg lesions without resulting in any mutations.
UV irradiation induces the formation of pyrimidine dimers, CPD and 6-4pp, which are repaired by Nucleotide excision repair (NER) (34, 35) . To date, there have been no reports that NER functions in the mitochondria of mammalian cells (2, 35) . Thus, UV-induced lesions would be a severe challenge to mitochondria genomic integrity. Using the 30-mer oligonucleotides containing CPD or 6-4pp ( Figure 5A ), mtRNAP generated 11 nucleotides ( Figure 5B, lanes 1-8) , indicating that mtRNAP was unable to incorporate any ribonucleotides opposite the UV lesions, and the enzyme was then stalled. Upon examining the ribonucleotide preference opposite an UV lesion ( Figure 5C ), it was observed that mtRNAP could not incorporate any rNTPs opposite the CPD or 6-4pp sites ( Figure 5D, lanes 1-8) , indicating that the enzyme completely stalls.
Mammalian mtRNAP shares significant amino acid similarity with a single-subunit T7 bacteriophage RNAP (T7RNAP), especially in the residues and domain structure of the active site (18) . We examined the effects of oxidative DNA lesions on the RNA synthesis catalysed by T7RNAP instead of mtRNAP. Using oligonucleotides containing a single 8-oxoG site ( Figure 6A ), T7RNAP could catalyse some translesion RNA synthesis and could also generate some RNA products -4) , 5R-Tg (lanes 5-8) and 5S-Tg (lanes 9-12) sites in the RNA/DNA complex were incubated with increasing amounts of mtRNA polymerase (0, 9, 18 and 36 fmol) at 32°C for 20 min. The samples were subjected to 16% polyacrylamide/7.5% urea gel electrophoresis. 1-4) , 5R-Tg (lanes 5-8) and 5S-Tg (lanes 9-12) sites in the RNA/DNA complex were incubated with mtRNA polymerase (36 fmol) at 32°C for 5 min. The samples were subjected to 20% polyacrylamide/7.5% urea gel electrophoresis.
( Figure 6B , lane 4) similar to mtRNAP ( Figure 1B, lanes  6-8) . Additionally, an AP site also strongly blocked the RNA synthesis of T7RNAP ( Figure 6B, lane 6) . However, unlike mtRNAP, this enzyme was unable to catalyse any translesion RNA synthesis past 5R-Tg or 5S-Tg sites ( Figure 6C , lane 4 or 6). The amount of bypassed transcripts from 5R-Tg or 5S-Tg was 3 or 3%, respectively. To examine the ribonucleotide preference of T7RNAP opposite the DNA lesions, standing start transcriptions were performed. T7RNAP preferred to incorporate rAMP opposite the lesions (data not shown). This finding indicates that T7RNAP produces mutant RNA past 8-oxoG but, unlike mtRNAP, is unable to produce any RNA transcripts past Tgs.
Discussion
Oxidative DNA lesions accumulate more in the mtDNA than in the nDNA (14, 31) . Because mitochondrial transcription differs from nuclear transcription, the effect of DNA lesions on the transcription in the mitochondria is thought to be unique. Here, we showed that mtRNAP bypassed the oxidative DNA lesions (8-oxoG, 5R-Tg and 5S-Tg), although it paused at the lesions and resulted in RNA transcripts containing a mutation, and the enzyme was unable to bypass UV-induced DNA lesions (CPD or 6-4pp) and AP sites. These data might indicate that the unique mtRNAP transcription of mitochondria is well tolerated by the damage effects of oxidative DNA lesions but not by that of UV-induced DNA lesions or AP sites.
mtRNAP vs. oxidative DNA lesions
In an oxygen-consuming cell, 8-oxoG is one of the major DNA lesions induced upon oxidative stress. The lesions are detected not only in the nucleus but also in the mitochondria (2, 31) . The repair enzyme 8-oxoG DNA glycosylase, OGG1, has two isoforms generated by its alternative splicing, each of which selectively localises and functions at either the nucleus or the mitochondria. However, under oxidative stress conditions, the accumulation of 8-oxoG in both of these organelles is thought to cause apoptosis. Previously, we and other groups reported that RNAPII in the nucleus could bypass an 8-oxoG lesion, and the bypass efficiency of 8-oxoG was enhanced in the presence of transcription factor SII (26, 33, 36) . Our data indicated that mtRNAP was able to bypass the lesion. If 8-oxoG completely blocks the transcription by mtRNAP, significant mitochondria dysfunction will occur due to the shortage of essential gene expression levels. Therefore, the translesion RNA synthesis might be involved in the increased accumulation of 8-oxoG.
Interestingly, the transcript generated by the translesion RNA synthesis of 8-oxoG contained a G:C to A:T transversion. This observation is consistent with previously published data that show the transcript read from 8-oxoG templates by RNAPII contains the same transversion (36) (37) (38) . When the capacity of 8-oxoG repair enzymes is insufficient and/or the amount of 8-oxoG is excessive in the mitochondria, the lesions and their mutant transcripts will accumulate in the mtDNA genome. As a result, the protein generated by the mutant transcripts might lead to significant dysfunction in living cells.
In the case of the two isomeric 5R-Tg and 5S-Tg sites that are highly cytotoxic lesions in living cells, mtRNAP could significantly bypass both lesions. Because Tg is a distorting lesion that blocks replicative DNA polymerase, this lesion is thought to be subject to translesion DNA polymerase (32, 39) . In the nucleus, RNAPII itself cannot bypass the lesion, but in the presence of transcriptional factor IIF, the transcription elongation is able to bypass the lesion (37) .
Our data indicated that the RNA products generated by mtRNAP from the DNA templates containing Tg contain no mutations, indicating that the DNA lesions induce no mutant protein in the mitochondria. Thus, Tg lesions might be less severe than 8-oxoG lesions in the mitochondria.
In the case of oxidative DNA lesions, mtRNAP eventually bypassed the lesions, and fewer products were generated than with a normal template containing no DNA lesion. These findings are consistent with previously published data obtained using RNAPII transcription reactions of a nuclear extract (33, 36) . In the cell, translesion RNA synthesis at oxidative lesions might be an anti-ROS defence function. The mtRNAP that catalyses translesion RNA synthesis might be able to tolerate the mitochondrial function to change in an environment containing ROS from the side effects of an ATP generation reaction. However, we cannot rule out the possibility that mtRNAP accurately bypasses the lesions with the assistance of other factors, similar to the manner in which RNAPII is better able to bypass lesions in the presence of TFIIF and/or TFIIS. In addition, we used in vitro RNA synthesis assays that the non-transcribed strand is not present from the active site in mtRNAP, therefore we also cannot rule out the possibility that the absence of the strand affect the ability of mtRNAP to bypass certain lesions.
mtRNAP vs. UV-induced DNA lesions
The mitochondria in human cells lack the enzymes for NER, which is able to remove UV-induced DNA lesions (CPD and 6-4pp) and other bulky DNA adducts on DNA (40) . As previously reported in the case of these bulky lesions (24, 27, 35) , RNA polymerases, such as DNA polymerases, are blocked. Our data indicated that mtRNAP transcriptions were completely inhibited by these UV-induced DNA lesions. Therefore, if there is no other DNA damage avoidance machinery to remove and/or bypass the transcription of the lesions, the mitochondria will lose essential transcripts for ATP generation in the cells. Conversely, the number of mitochondria per human cell varies with the cell type (approximately [10] [11] [12] [13] [14] [15] . If a mitochondrion dysfunctions due to UV-induced DNA lesions, other mitochondria without the DNA lesions would function, and the cells might be able to survive under the mitochondrial conditions involving ROS-induced DNA lesions. In normal cells, defence machinery against ROS rather than UV radiation might be important.
Supplementary data
Supplementary Figure S1 is available at Mutagenesis Online.
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